Study demonstrates that computationally-designed miniproteins can modulate GPCR activity in native cellular environments, expanding access to a major drug target family.
Drug discovery still relies on destroying cells to understand how they respond, but new real-time measurement approaches are beginning to reveal biology in motion rather than in snapshots.